Omnicell
OMCLOmnicell is a healthcare technology provider that specializes in autonomous medication management and dispensing automation.
Earnings
Next report
Oct 29, 2026 (In 3 weeks)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Omnicell is a healthcare technology provider that specializes in autonomous medication management and dispensing automation. The company provides an integrated suite of hardware and software solutions designed to reduce medication errors, mitigate drug diversion, and automate administrative tasks for clinicians. Its core value proposition centers on the 'Autonomous Pharmacy' vision, which leverages an intelligence ecosystem to improve operational efficiency and patient safety across the continuum of care.
A market leader in automated dispensing and central pharmacy robotics, positioning itself as a pioneer of the Autonomous Pharmacy framework.
FAQ
- What is Omnicell's market cap?
- Omnicell (OMCL) has a market capitalization of $1.5B and trades on NASDAQ.
- What is Omnicell's revenue and profitability?
- Omnicell generated $1.2B in trailing twelve-month revenue with net income of $46.7M, representing a net margin of 1.7%. Gross margin stands at 44.8%, with free cash flow of $142.6M. The latest reported period is Q2 2026.
- Who are Omnicell's competitors?
- Omnicell's key competitors include Becton, Dickinson and Company, Baxter International Inc., BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Where is Omnicell headquartered?
- Omnicell is headquartered in United States of America and employs approximately 3,590 people. It has been publicly traded since 2001.
